SG11202111925RA - Vasoactive intestinal peptide (vip) for use in the treatment of drug-induced pneumonitis - Google Patents
Vasoactive intestinal peptide (vip) for use in the treatment of drug-induced pneumonitisInfo
- Publication number
- SG11202111925RA SG11202111925RA SG11202111925RA SG11202111925RA SG11202111925RA SG 11202111925R A SG11202111925R A SG 11202111925RA SG 11202111925R A SG11202111925R A SG 11202111925RA SG 11202111925R A SG11202111925R A SG 11202111925RA SG 11202111925R A SG11202111925R A SG 11202111925RA
- Authority
- SG
- Singapore
- Prior art keywords
- vip
- drug
- treatment
- vasoactive intestinal
- intestinal peptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19000219 | 2019-05-07 | ||
| PCT/EP2020/062420 WO2020225246A1 (en) | 2019-05-07 | 2020-05-05 | Vasoactive intestinal peptide (vip) for use in the treatment of drug-induced pneumonitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202111925RA true SG11202111925RA (en) | 2021-11-29 |
Family
ID=66541991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202111925RA SG11202111925RA (en) | 2019-05-07 | 2020-05-05 | Vasoactive intestinal peptide (vip) for use in the treatment of drug-induced pneumonitis |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220202906A1 (en) |
| EP (1) | EP3965801A1 (en) |
| JP (1) | JP2022531920A (en) |
| KR (1) | KR20220005495A (en) |
| CN (1) | CN114144195A (en) |
| AU (1) | AU2020269901A1 (en) |
| BR (1) | BR112021022170A2 (en) |
| CA (1) | CA3138891A1 (en) |
| CH (1) | CH717180B1 (en) |
| IL (1) | IL287854A (en) |
| MX (1) | MX2021013496A (en) |
| SG (1) | SG11202111925RA (en) |
| WO (1) | WO2020225246A1 (en) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002220720B2 (en) * | 2000-11-28 | 2006-09-14 | Mondobiotech Ag | Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| US9216239B2 (en) * | 2001-06-08 | 2015-12-22 | Leo Rubin | Medical device for intra-lumenal delivery of pharmaceutical agents |
| EP1468021A2 (en) | 2002-01-26 | 2004-10-20 | Mondobiotech Laboratories Anstalt | Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of chronic obstructive pulmonary disease |
| DE60326723D1 (en) | 2002-06-10 | 2009-04-30 | Mondobiotech Licensing Out Ag | USE OF COMPOSITIONS WITH THE BIOLOGICAL ACTIVITY OF VASOACTIVE INTESTINAL PEPTIDES FOR THE TREATMENT OF SARCOIDOSIS |
| DE502004009530D1 (en) * | 2003-07-14 | 2009-07-09 | Mondobiotech Ag | SUBSTANCES WITH BIOLOGICAL ACTIVITY OF VASOACTIVE INTESTINAL PEPTIDE FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASES |
| WO2005014030A1 (en) * | 2003-07-24 | 2005-02-17 | Lutz-Henning Block | Method for treating lung diseases associated with ventilation-perfusion mismatches |
| EP2152741B1 (en) | 2007-05-21 | 2011-09-21 | Res International Sarl | Peptides with improved properties having the biological activity of vasoactive intestinal peptide (vip) and their use for the treatment of lung diseases |
| CA2873553C (en) * | 2011-06-06 | 2020-01-28 | Phasebio Pharmaceuticals, Inc. | Use of modified vasoactive intestinal peptides in the treatment of hypertension |
| WO2015104596A1 (en) | 2014-01-10 | 2015-07-16 | Ipp Dr Hayley | Vasoactive intestinal peptide |
-
2020
- 2020-05-05 CH CH70082/21A patent/CH717180B1/en unknown
- 2020-05-05 MX MX2021013496A patent/MX2021013496A/en unknown
- 2020-05-05 US US17/595,025 patent/US20220202906A1/en active Pending
- 2020-05-05 BR BR112021022170A patent/BR112021022170A2/en unknown
- 2020-05-05 EP EP20722593.9A patent/EP3965801A1/en active Pending
- 2020-05-05 AU AU2020269901A patent/AU2020269901A1/en not_active Abandoned
- 2020-05-05 WO PCT/EP2020/062420 patent/WO2020225246A1/en active Application Filing
- 2020-05-05 CA CA3138891A patent/CA3138891A1/en active Pending
- 2020-05-05 KR KR1020217037533A patent/KR20220005495A/en not_active Application Discontinuation
- 2020-05-05 SG SG11202111925RA patent/SG11202111925RA/en unknown
- 2020-05-05 JP JP2021566293A patent/JP2022531920A/en not_active Withdrawn
- 2020-05-05 CN CN202080034005.XA patent/CN114144195A/en active Pending
-
2021
- 2021-11-04 IL IL287854A patent/IL287854A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020225246A1 (en) | 2020-11-12 |
| EP3965801A1 (en) | 2022-03-16 |
| US20220202906A1 (en) | 2022-06-30 |
| AU2020269901A1 (en) | 2021-12-23 |
| BR112021022170A2 (en) | 2021-12-21 |
| CH717180B1 (en) | 2022-03-31 |
| CN114144195A (en) | 2022-03-04 |
| IL287854A (en) | 2022-01-01 |
| KR20220005495A (en) | 2022-01-13 |
| CA3138891A1 (en) | 2020-11-12 |
| MX2021013496A (en) | 2022-01-06 |
| JP2022531920A (en) | 2022-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL290090A (en) | Heterotandem bicyclic peptide complex | |
| IL289464A (en) | Relaxin analogs and methods of using the same | |
| SG11202106771QA (en) | Single-molecule protein and peptide sequencing | |
| SG11202112921VA (en) | Multispecific proteins | |
| GB201906105D0 (en) | Ceramic composite | |
| GB2591554B (en) | Composiitons and methods and uses relating thereto | |
| EP4061302A4 (en) | Massage apparatus | |
| SG11202103027UA (en) | Glycated hemoglobin (%) assay method | |
| IL287854A (en) | Vasoactive intestinal peptide (vip) for use in the treatment of drug-induced pneumonitis | |
| EP4081651A4 (en) | Composition comprising mir-335 | |
| EP4048249A4 (en) | Methods of treating the symptoms of autism spectrum disorder | |
| GB202116918D0 (en) | Compressor for dewatering and processes involving same | |
| EP3852589A4 (en) | Walk-in bath | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| EP4041267A4 (en) | Yeast for the treatment of allergy | |
| IL286000A (en) | Esketamine for the treatment of depression | |
| EP3880228A4 (en) | Compositions and uses of vasoactive intestinal peptide (vip) antagonists | |
| IL286533A (en) | Compounds for use in the treatment of adcy5-related dyskinesia | |
| EP3861340A4 (en) | Analyzing hormone panels for the prediction of spontaneous preterm delivery | |
| KR102313739B9 (en) | Plating Solution Composition having Ruthenium and Method of plating using the same | |
| GB201906977D0 (en) | Forceps and kits for forming the same | |
| FI12672U1 (en) | Multi-purpose apparatus | |
| IL281090A (en) | Alternative processes for the preparation of tubulysins and intermediates thereof | |
| GB202201715D0 (en) | Protein | |
| GB202201714D0 (en) | Protein |